病理驱动的上皮硫化物丢失重编程氧化还原蛋白质组并触发巴雷特食管
该研究通过蛋白质组学和化学蛋白质组学分析两个患者队列,发现胃食管反流病(GERD)诱导的硫化氢(H2S)氧化丢失及其分解代谢增强,引发鳞状上皮中蛋白质过硫化(PSSH)蛋白质组的早期重塑,并在巴雷特食管(BE)中扩大,影响超过1300种蛋白质。H2S耗竭加速化生转化,而H2S供体可逆转这些效应。15-羟基前列腺素脱氢酶的PSSH可逆性抑制其活性,保护酶并允许PGE2降解恢复。
要点
- GERD诱导的H2S丢失触发鳞状上皮PSSH蛋白质组重塑,并在BE中扩大。
- H2S耗竭加速化生转化,H2S供体在实验模型中逆转此效应。
- 15-PGDH的PSSH可逆抑制其活性,保护酶并恢复PGE2降解。
核心结论
- H2S丢失和过硫化蛋白质组重塑是BE发病中上皮重编程和氧化还原失衡的核心可成药驱动因素。
研究设计与样本
- 应用蛋白质组学和化学蛋白质组学在两个患者队列中绘制并验证健康、GERD暴露和化生上皮的PSSH及总蛋白质组谱。
- 使用慢性GERD和BE的体外和体内模型,通过遗传和药理学手段调节H2S水平。
主要发现
- GERD诱导的H2S氧化丢失及其分解代谢增强引发鳞状上皮早期PSSH蛋白质组重塑,在BE中扩大并影响临床样本中超过1300种蛋白质。
- PSSH改变包括调节前列腺素E2(PGE2)积累的酶,PGE2是BE发生和进展的已知驱动因素。
- H2S耗竭加速化生转化,而H2S供体在实验模型中逆转这些效应。
- 15-羟基前列腺素脱氢酶的PSSH可逆抑制其活性,保护酶并允许PGE2降解恢复,不同于不可逆氧化。
临床怎么用
- 硫化氢丢失和过硫化蛋白质组重塑可能作为BE的潜在生物标志物和可成药靶点。
- H2S供体在实验模型中逆转化生转化,提示其治疗BE的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Barrett's esophagus (BE), a metaplastic transformation driven by gastroesophageal reflux disease (GERD), induces oxidative stress but the underlying redox mechanisms remain poorly understood. Protein persulfidation (PSSH), a redox-sensitive, reversible, and antioxidative post-translational modification regulated by hydrogen sulfide (H2S) metabolism, has not been explored in this context. Here, we identify epithelial PSSH as a key regulator of this premalignant process. METHODS: We applied proteomics and chemoproteomics in 2 patient cohorts to map and validate PSSH and total proteome profiles across healthy (squamous), GERD-exposed, and metaplastic epithelium. Using in vitro and in vivo models of chronic GERD and BE, we modulated H2S levels genetically and pharmacologically. Mechanistic and functional effects were assessed using tissue biopsies or recombinant human proteins. RESULTS: GERD-induced oxidative loss of H2S and its enhanced catabolism initiated early PSSH proteome remodeling in squamous epithelium, which expanded in BE and affected >1300 proteins in clinical samples, indicating potential biomarkers. This also included altered persulfidation of enzymes regulating accumulation of prostaglandin E2 (PGE2), a well-established driver of BE development and progression. H2S depletion accelerated metaplastic transformation, whereas H2S donors reversed these effects in experimental models. PSSH of 15-hydroxyprostaglandin dehydrogenase reversibly suppressed its activity, protecting the enzyme and, unlike irreversible oxidation, allowing recovery of PGE2 degradation. CONCLUSIONS: These findings redefine the origin of PGE2 accumulation in metaplasia and establish sulfide loss and persulfidomic remodeling as central, druggable drivers of epithelial reprogramming and redox imbalance in BE pathogenesis.
引用
- Korbut E, Wierdak M, Vignane T, et al. Pathology-Driven Epithelial Sulfide Loss Reprograms the Redox Proteome and Triggers Barrett's Esophagus. Gastroenterology. 2026. PMID: 42235802. doi:10.1053/j.gastro.2026.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。